Latest Industry Insights

In this interview, Dr. Denise Heaney discusses how molecular diagnostics are reshaping antimicrobial stewardship and redefining the standard of care for infectious diseases.

Technology Networks recently spoke with Santhosh Nair to learn more about polyautoimmunity and the evolving role of clinical laboratories in its detection and management.

In this interview, Dr. Anderson discusses the advantages of dd-cfDNA as a transplant monitoring tool and the regulatory and clinical hurdles that must be overcome before dd-cfDNA testing can be fully adopted in healthcare.

In this interview, Dr. Denise Teber, a scientific expert in molecular biology at Charles River Laboratories, discusses how ddPCR is being used to improve contamination risk management.

In the heart of Cambridge, a quiet revolution is reshaping the way science startups scale: one built not only on breakthrough molecules and patents, but also on collaborative spaces, shared values and pragmatic support.

This article explores the unique characteristics and challenges of life sciences marketing, offering insights on how to achieve meaningful engagement with a highly specialized audience.

In this interview, we explore the relationship between allergies and mental health, and how advances in diagnostic testing could help clinicians offer more personalized patient care.

Dr. Jennifer Schneider discusses Centauri Therapeutics' novel approach to combating Gram-negative infections, its first clinical candidate from the ABX-01 program and how the platform could help shape the future of anti-infective therapy.

Anti-infective discovery is evolving with AI and robotics – learn how UK researchers aim to cut development time and improve success rates.

Unlike injectable weight loss drugs that often serve as a temporary fix, Elcella seeks to naturally activate the gut’s own appetite-regulating mechanisms, offering a new path to long-term health and sustainable weight management.